Non-Drowsy Sudafed Decongestant (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. By stimulating α1 and α2 receptors on the blood vessels of the nasal lining, it causes vasoconstriction, which reduces blood flow, edema, and excess mucus. The narrowed vessels open the nasal passages, providing rapid decongestion.

The appropriate dose is determined by a qualified prescriber based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but exact frequency and duration should follow the healthcare professional’s instructions and the product label.

Safety data for Xylometazoline Hydrochloride during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using this product to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Xylometazoline belongs to the imidazoline class, offering a rapid onset of action and a duration of relief of up to 12 hours. Compared with phenylephrine, it generally provides longer-lasting decongestion with fewer systemic effects, while oxymetazoline, another imidazoline, has a similar profile but may have a slightly higher risk of rebound congestion if used beyond recommended limits.

Store the nasal spray at ambient temperature, preferably below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and extreme heat. Ensure the cap is tightly closed after each use to maintain product integrity.

The product is applied topically to each nostril using the spray pump. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle into a nostril, and press the pump to deliver the recommended number of sprays. Avoid inhaling deeply during administration to keep the spray localized.

Serious but rare risks include nasal septum perforation, significant hypertension, and severe allergic reactions such as rash, swelling, or anaphylaxis. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to Xylometazoline or any component of the formulation should avoid it. It is also contraindicated in patients with severe hypertension, recent heart attack, or those taking monoamine oxidase inhibitors unless directed by a physician. Children under 2 years of age should not use the product without medical supervision.